Annual EBITDA
$341.70M$33.37M+10.82%
Summary
- Current Value
- As of today, COLL annual EBITDA is $341.70M, up +10.82% on
- Historical Performance
- COLL annual EBITDA is up +294.77% over the past 3 years, and up +5498.14% over the past 5 years
- All-Time High Comparison
- COLL annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- COLL annual EBITDA is +97.17% above its 3-year low of $173.31M reached on an earlier date
- Sector Comparison
- COLL annual EBITDA is higher than 89.97% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $341.70M | +10.8% | +294.8% | +5498.1% | +2242.1% | |
| Quarterly EBITDA | $120.13M | +24.5% | +105.6% | +227.9% | +3350.2% | |
| TTM EBITDA | $388.72M | +7.5% | +258.8% | +345.9% | +10000.0% | |
| Price | $47.10 | +44.7% | +70.8% | +96.8% | – | |
| PE Ratio | 29.31 | +66.3% | – | -6.8% | – | |
| Annual Revenue | $631.45M | +11.4% | +128.1% | +112.8% | +100.0% | |
| Annual EPS | $1.86 | +43.6% | +0.0% | +373.4% | +185.6% | |
| Annual EBIT | $172.54M | +8.5% | +878.1% | +891.0% | +1170.3% | |
| Annual Net Income | $69.19M | +43.7% | -3.3% | +404.5% | +1848.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $341.70M | at high | |
| 5Y | $341.70M | at high | |
| All | $341.70M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $173.31M | N/A | +97.2% |
| 5Y | $86.56M | +294.8% | |
| All | -$93.43M | +465.7% |
EBITDA History
FAQ
What is the current annual EBITDA of COLL?
As of today, COLL annual EBITDA is $341.70M
What is 1-year change in COLL annual EBITDA?
COLL annual EBITDA is up +10.82% year-over-year
What is 3-year change in COLL annual EBITDA?
COLL annual EBITDA is up +294.77% over the past 3 years
How far is COLL annual EBITDA from its all-time high?
COLL annual EBITDA is currently at its all-time high
How does COLL annual EBITDA rank versus sector peers?
COLL annual EBITDA is higher than 89.97% of companies in Healthcare sector
When is COLL next annual earnings release?
The next annual earnings release for COLL is on
Quarterly EBITDA
$120.13M$27.84M+30.16%
Summary
- Current Value
- As of today, COLL quarterly EBITDA is $120.13M, up +30.16% on
- Historical Performance
- COLL quarterly EBITDA is up +24.52% year-over-year, and up +105.63% over the past 3 years
- All-Time High Comparison
- COLL quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- COLL quarterly EBITDA is +119.02% above its 3-year low of $54.85M reached on an earlier date
- Sector Comparison
- COLL quarterly EBITDA is higher than 89.67% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $120.13M | +30.2% | +24.5% | +105.6% | +227.9% | |
| Annual EBITDA | $341.70M | – | +10.8% | +294.8% | +5498.1% | |
| TTM EBITDA | $388.72M | +6.5% | +7.5% | +258.8% | +345.9% | |
| Price | $47.10 | +31.9% | +44.7% | +70.8% | +96.8% | |
| PE Ratio | 29.31 | +31.9% | +66.3% | – | -6.8% | |
| Quarterly Revenue | $209.36M | +11.4% | +31.4% | +64.8% | +164.4% | |
| Quarterly EPS | $0.84 | +143.3% | +213.2% | +6252.3% | +160.6% | |
| Quarterly EBIT | $63.62M | +78.3% | +16.3% | +210.8% | +224.2% | |
| Quarterly Net Income | $31.51M | +162.9% | +237.5% | +6794.3% | +179.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $120.13M | at high | |
| 3Y | $120.13M | at high | |
| 5Y | $120.13M | at high | |
| All | $120.13M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $80.15M | +49.9% | |
| 3Y | $54.85M | N/A | +119.0% |
| 5Y | -$9.39M | +1379.0% | |
| All | -$27.28M | +540.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of COLL?
As of today, COLL quarterly EBITDA is $120.13M
What is COLL quarterly EBITDA most recent change?
COLL quarterly EBITDA was up +30.16% on September 30, 2025
What is 1-year change in COLL quarterly EBITDA?
COLL quarterly EBITDA is up +24.52% year-over-year
How far is COLL quarterly EBITDA from its all-time high?
COLL quarterly EBITDA is currently at its all-time high
How does COLL quarterly EBITDA rank versus sector peers?
COLL quarterly EBITDA is higher than 89.67% of companies in Healthcare sector
When is COLL next earnings release?
The next earnings release for COLL is on
TTM EBITDA
$388.72M$23.65M+6.48%
Summary
- Current Value
- As of today, COLL TTM EBITDA is $388.72M, up +6.48% on
- Historical Performance
- COLL TTM EBITDA is up +7.54% year-over-year, and up +258.78% over the past 3 years
- All-Time High Comparison
- COLL TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- COLL TTM EBITDA is +125.23% above its 3-year low of $172.58M reached on an earlier date
- Sector Comparison
- COLL TTM EBITDA is higher than 89.13% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $388.72M | +6.5% | +7.5% | +258.8% | +345.9% | |
| Annual EBITDA | $341.70M | – | +10.8% | +294.8% | +5498.1% | |
| Quarterly EBITDA | $120.13M | +30.2% | +24.5% | +105.6% | +227.9% | |
| Price | $47.10 | +31.9% | +44.7% | +70.8% | +96.8% | |
| PE Ratio | 29.31 | +31.9% | +66.3% | – | -6.8% | |
| TTM Revenue | $757.07M | +7.1% | +26.3% | +109.3% | +145.8% | |
| TTM EPS | $1.61 | +55.1% | -30.7% | +227.4% | +222.2% | |
| TTM EBIT | $162.53M | +5.8% | -23.8% | +3320.3% | +318.2% | |
| TTM Net Income | $58.44M | +61.1% | -34.0% | +236.4% | +232.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $388.72M | at high | |
| 3Y | $388.72M | at high | |
| 5Y | $388.72M | at high | |
| All | $388.72M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $355.71M | +9.3% | |
| 3Y | $172.58M | N/A | +125.2% |
| 5Y | $65.42M | +494.1% | |
| All | -$100.85M | +485.4% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of COLL?
As of today, COLL TTM EBITDA is $388.72M
What is COLL TTM EBITDA most recent change?
COLL TTM EBITDA was up +6.48% on September 30, 2025
What is 1-year change in COLL TTM EBITDA?
COLL TTM EBITDA is up +7.54% year-over-year
How far is COLL TTM EBITDA from its all-time high?
COLL TTM EBITDA is currently at its all-time high
How does COLL TTM EBITDA rank versus sector peers?
COLL TTM EBITDA is higher than 89.13% of companies in Healthcare sector
When is COLL next earnings release?
The next earnings release for COLL is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- COLL Official Website www.collegiumpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1267565/000110465925107391/0001104659-25-107391-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1267565/000155837025001801/0001558370-25-001801-index.htm
- COLL Profile on Yahoo Finance finance.yahoo.com/quote/COLL
- COLL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/coll